Literature DB >> 33823268

Application of microbial 3-ketosteroid Δ1-dehydrogenases in biotechnology.

Ali Rohman1, Bauke W Dijkstra2.   

Abstract

3-Ketosteroid Δ1-dehydrogenase catalyzes the 1(2)-dehydrogenation of 3-ketosteroid substrates using flavin adenine dinucleotide as a cofactor. The enzyme plays a crucial role in microbial steroid degradation, both under aerobic and anaerobic conditions, by initiating the opening of the steroid nucleus. Indeed, many microorganisms are known to possess one or more 3-ketosteroid Δ1-dehydrogenases. In the pharmaceutical industry, 3-ketosteroid Δ1-dehydrogenase activity is exploited to produce Δ1-3-ketosteroids, a class of steroids that display various biological activities. Many of them are used as active pharmaceutical ingredients in drug products, or as key precursors to produce pharmaceutically important steroids. Since 3-ketosteroid Δ1-dehydrogenase activity requires electron acceptors, among other considerations, Δ1-3-ketosteroid production has been industrially implemented using whole-cell fermentation with growing or metabolically active resting cells, in which the electron acceptors are available, rather than using the isolated enzyme. In this review we discuss biotechnological applications of microbial 3-ketosteroid Δ1-dehydrogenases, covering commonly used steroid-1(2)-dehydrogenating microorganisms, the bioprocess for preparing Δ1-3-ketosteroids, genetic engineering of 3-ketosteroid Δ1-dehydrogenases and related genes for constructing new, productive industrial strains, and microbial fermentation strategies for enhancing the product yield. Furthermore, we also highlight the recent development in the use of isolated 3-ketosteroid Δ1-dehydrogenases combined with a FAD cofactor regeneration system. Finally, in a somewhat different context, we summarize the role of 3-ketosteroid Δ1-dehydrogenase in cholesterol degradation by Mycobacterium tuberculosis and other mycobacteria. Because the enzyme is essential for the pathogenicity of these organisms, it may be a potential target for drug development to combat mycobacterial infections.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FAD regeneration; Metabolic engineering; Microbial transformation; Pharmaceuticals; Steroid 1(2)-dehydrogenation; Steroid bioconversion; Tuberculosis; Δ(1)-3-ketosteroid

Year:  2021        PMID: 33823268     DOI: 10.1016/j.biotechadv.2021.107751

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  4 in total

Review 1.  Rational development of mycobacteria cell factory for advancing the steroid biomanufacturing.

Authors:  Xin-Xin Wang; Xia Ke; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  World J Microbiol Biotechnol       Date:  2022-08-17       Impact factor: 4.253

2.  Further Studies on the 3-Ketosteroid 9α-Hydroxylase of Rhodococcus ruber Chol-4, a Rieske Oxygenase of the Steroid Degradation Pathway.

Authors:  Sara Baldanta; Juana María Navarro Llorens; Govinda Guevara
Journal:  Microorganisms       Date:  2021-05-29

3.  Universal capability of 3-ketosteroid Δ1-dehydrogenases to catalyze Δ1-dehydrogenation of C17-substituted steroids.

Authors:  Patrycja Wójcik; Michał Glanowski; Agnieszka M Wojtkiewicz; Ali Rohman; Maciej Szaleniec
Journal:  Microb Cell Fact       Date:  2021-06-23       Impact factor: 5.328

4.  A New 3-Ketosteroid-Δ1-Dehydrogenase with High Activity and Broad Substrate Scope for Efficient Transformation of Hydrocortisone at High Substrate Concentration.

Authors:  Yu Wang; Rui Zhang; Jinhui Feng; Qiaqing Wu; Dunming Zhu; Yanhe Ma
Journal:  Microorganisms       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.